معرفی
Dr. Harikesh Dubey is a Researcher at the Institute for Quantitative Health Science & Engineering (IQHSE), part of Michigan State University's College of Engineering. His work focuses on neuropharmacology, Alzheimer’s disease mechanisms, drug safety, and the microbiome-gut-brain axis. Dr. Dubey’s interdisciplinary research bridges pharmacology, neuroscience, and molecular biology, with a particular emphasis on therapeutic interventions for neurodegenerative disorders and drug toxicity analysis.
His research interests include nitric oxide modulators in Alzheimer’s pathogenesis, pharmacovigilance of emerging therapies (e.g., immune checkpoint inhibitors and kinase inhibitors), and the impact of human microbiota on neurobehavioral outcomes. He employs preclinical models to study cognitive deficits, oxidative stress, and myelination processes.
Dr. Dubey has contributed to over 30 peer-reviewed articles since 2011, with recent work emphasizing drug safety profiling using EudraVigilance and VigiAccess databases. His studies on S-nitrosoglutathione and L-arginine highlight novel neuroprotective strategies. He collaborates with IQHSE’s multidisciplinary teams to advance translational research in health science and engineering.
While no formal awards or student advisees are listed, his contributions to drug safety and Alzheimer’s research underscore his commitment to improving therapeutic efficacy and patient outcomes through rigorous scientific inquiry.
